Earnings History Data for Outlook Therapeutics, Inc. (OTLK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Outlook Therapeutics, Inc.

Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-08-2024 PM OTLK Outlook Therapeutics, Inc. 171.80 -0.83 -1.06 -1.60 Outlook Therapeutics Non-GAAP EPS of -$0.83 beats by $0.01
[8/14/2024 7:24 AM]
7.38 -0.38 
(-4.84%)
7.81 0.06 
(0.77%)
4.00 - 32.00 128,858 170,000 2,301
14-02-2024 PM OTLK Outlook Therapeutics, Inc. 107.77 -0.04 -0.05 -0.08 Outlook Therapeutics GAAP EPS of -$0.04 beats by $0.01
[2/14/2024 8:12 AM]
0.4157 0.02 
(3.92%)
0.43 0.03 
(8.25%)
0.20 - 2.03 1,072,673 1,490,000 32,430
22-12-2023 PM OTLK Oncobiologics 109.00 -0.05 -0.05 0.00 Outlook Therapeutics GAAP EPS of -$0.24
[12/22/2023 11:45 AM]
0.4181 -0.01 
(-2.29%)
0.44 0.01 
(2.13%)
0.20 - 2.03 1,089,121 1,390,000 28,125
14-08-2023 PM OTLK Oncobiologics 413.00 -0.08 -0.04 0.00 Outlook Therapeutics GAAP EPS of -$0.08
[8/14/2023 11:15 AM]
1.56 -0.04 
(-2.50%)
1.58 -0.02 
(-1.25%)
0.80 - 2.03 2,198,441 900,000 15,706
14-02-2023 PM 9:05 AM ET
(Feb 14)
OTLK Outlook Therapeutics, Inc. 328.53 -0.08 -0.04 -0.08 Outlook Therapeutics GAAP EPS of -$0.08
[2/14/2023 8:30 AM]
1.20 0.0 
(0.00%)
1.20 0.0 
(0.00%)
0.68 - 2.12 412,731 600,000 1,739
29-12-2022 PM OTLK Outlook Therapeutics, Inc. 241.97 N/A -0.07 -0.08 Outlook Therapeutics GAAP EPS of -$0.31 in-line
[12/29/2022 9:45 AM]
1.08 0.07 
(6.93%)
1.04 0.03 
(2.97%)
0.68 - 2.12 800,688 640,000 12,885
10-08-2022 PM 8:05 AM ET
(Aug 10)
OTLK Oncobiologics 276.00 -0.08 -0.08 0.00 Outlook Therapeutics GAAP EPS of -$0.08 misses by $0.01
[8/10/2022 8:20 AM]
1.23 0.04 
(3.36%)
1.17 -0.02 
(-1.68%)
0.68 - 2.87 202,278 510,000 4,906
14-02-2022 PM OTLK Oncobiologics 309.00 -0.08 -0.07 0.00 Outlook Therapeutics GAAP EPS of -$0.08
[2/14/2022 8:12 AM]
1.33 -0.02 
(-1.48%)
1.34 -0.01 
(-0.74%)
1.19 - 3.27 544,070 970,000 920
14-05-2021 PM OTLK Oncobiologics, Inc. 344.00 -0.09 -0.11 0.00 Outlook Therapeutics EPS misses by $0.01
[5/14/2021 8:47 AM]
2.10 0.16 
(8.25%)
2.06 0.12 
(6.16%)
0.58 - 4.26 726,590 820,000 9,582
24-12-2020 ?? 8:05 AM ET
(Dec 23)
OTLK Outlook Therapeutics, Inc. 186.96 N/A -0.10 -0.24 Outlook Therapeutics EPS beats by $0.01
[12/23/2020 9:15 AM]
1.55 -0.03 
(-1.90%)
1.44 -0.11 
(-7.10%)
0.50 - 1.73 933,574 873,319 500